Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05703386 · ClinicalTrials.gov registry record

Imaging the Pathogenesis of Cerebral Small Vessel Disease

A clinical trial of Hypertension and Diabetes, sponsored by Johns Hopkins University.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT05703386 is a study of Hypertension and Diabetes that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05703386, a study of Hypertension and Diabetes, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use serial MRI scanning to gain insights into the pathogenesis of CSVD.

Study Locations (1)

Maryland

  • Kennedy Krieger Institute - Baltimore

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-11-08
Est. Completion 2027-03-31

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05703386

The ClinicalTrials.gov registry entry for NCT05703386 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT05703386 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05703386 about?

NCT05703386 is a clinical study titled "Imaging the Pathogenesis of Cerebral Small Vessel Disease". Cerebral small vessel disease (CSVD) can lead to vascular cognitive impairment and dementia (VCID). The hallmark of CSVD is the appearance and progression of white matter hyperintensities (WMH) on MRI. The goal of this study it to recruit and follow individuals at risk for WMH progression and use se...

What is the current status of trial NCT05703386?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-11-08. Estimated completion is 2027-03-31.

What conditions does trial NCT05703386 study?

This clinical trial studies the following conditions: Hypertension, Diabetes, Ischemic Stroke, Hyperlipidemias.

Who is sponsoring clinical trial NCT05703386?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05703386 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.